Uncommon Gynecologic Cancers.

Intro -- Title Page -- Copyright -- Contents -- List of Contributors -- Preface -- Part 1 General Principles -- Chapter 1 Molecular Targets in Gynecologic Cancers -- Introduction -- Phosphoinositol 3-kinase (PI3K) pathway -- Mitogen-activated protein kinase (MAPK) pathway -- Human epidermal growth factor receptor 2 (HER2) -- Vascular endothelial growth factor (VEGF) -- Poly (adenosine) diphosphate [ADP]-ribose polymerase (PARP) -- References -- Chapter 2 Imaging of Rare Gynecologic Tumors -- Imaging guidelines -- Imaging of uncommon ovarian malignancies -- Imaging of uncommon uterine and endometrial malignancies -- Imaging of uncommon cervical malignancies -- Imaging of uncommon vaginal and vulvar malignancies -- Conclusion -- References -- Chapter 3 Pathology Overview of Rare Gynecologic Tumors -- Ovary -- The Uterine Corpus -- Uterine Cervix -- Vagina and Vulva -- Fallopian Tube -- Peritoneum -- References -- Part 2 Rare Ovarian Cancers -- Chapter 4 Ovarian Clear Cell Carcinoma -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Prognostic factors -- Treatment -- Future directions -- Surveillance -- Conclusions -- References -- Chapter 5 Mucinous Epithelial Ovarian Cancer -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Prognostic factors -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 6 Pseudomyxoma Peritonei -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical Presentation -- Pretreatment Evaluation -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 7 Squamous Cell Carcinoma of the Ovary -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Treatment -- Survival -- Surgical management.

Fertility-sparing/conservative surgery -- Chemotherapy -- Radiation -- Surveillance -- Conclusions -- References -- Chapter 8 Endometriosis-Associated Ovarian Cancer -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 9 Carcinosarcoma of the Ovary -- Introduction -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Prognostic factors -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 10 Malignant Germ Cell Tumors of the Ovary -- Introduction -- Epidemiology -- Pathology -- Immature teratoma -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Prognostic factors -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 11 Malignant Sex Cord-Stromal Tumors of the Ovary -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Prognostic factors -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 12 Small Cell and Neuroendocrine Cancers of the Ovary -- Introduction -- Small cell carcinoma -- NSCNEC of the ovary -- Conclusions -- References -- Chapter 13 Carcinoid Tumors of the Ovary -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Treatment -- Surveillance -- References -- Part 3 Rare Uterine Cancers -- Chapter 14 Uterine Carcinosarcoma -- Epidemiology and presentation -- Pathology -- Pathogenesis -- Surgical treatment -- Adjuvant therapy -- Choice of chemotherapy -- What is the role of RT? -- Treatment for recurrent disease -- Prognosis -- Surveillance -- Conclusions -- References -- Chapter 15 Uterine Leiomyosarcoma -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation.

Pretreatment evaluation -- Prognostic factors -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 16 Mucinous Tumors of the Uterine Corpus -- Introduction -- Epidemiology -- Pathology -- Clinical presentation -- Pretreatment evaluation -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 17 Uterine Clear Cell Carcinoma -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 18 Updates on the Management of Uterine Serous Carcinoma -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 19 Endometrial Stromal Sarcomas -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Prognostic factors -- Treatment -- Surveillance -- Conclusions -- References -- Part 4 Rare Cancers of the Cervix, Vulva and Vagina -- Chapter 20 Small Cell Neuroendocrine Carcinoma of the Cervix -- Introduction -- Epidemiology -- Pathology -- Clinical presentation -- Pretreatment evaluation -- Prognostic factors -- Treatment -- Conclusions -- References -- Chapter 21 Primary Malignant Melanoma of the Vagina and Vulva -- Introduction -- Epidemiology -- Pathology -- Pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Treatment -- Surveillance -- Prognosis -- Conclusions -- References -- Chapter 22 Sarcomas of the Vulva and Vagina -- Introduction -- Epidemiology -- Pathology/pathogenesis -- Clinical presentation -- Pretreatment evaluation -- Treatment -- Surveillance -- Conclusions -- References -- Chapter 23 Gestational Trophoblastic Disease -- Introduction -- Epidemiology -- Pathogenesis -- Pathology -- Clinical presentation.

Pretreatment evaluation -- Treatment -- Surveillance -- Conclusions -- References -- Index -- End User License Agreement.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.